The company has recalled the products as the bottle cap can be cracked open by children who can gain unintended access to the capsules that are used for oral chemotherapy. The consumption of the drug can lead to the possible risk of poisoning.
While no injury or incidents have been reported yet, the company has recalled the bottles as a precautionary measure.
The capsules distributed in 5- and 14-count brown glass bottles have white plastic child-resistant caps with a white label that has ‘Temozolomide’ in black printed on its body.
The company has instructed its consumers to inspect the bottle caps and to report to them in case of cracked caps.
Customers have also been urged to store the bottles at high places, out of sight and reach of young children to avoid any incident. People using the drug have been asked to continue consuming it as directed.
The drug was sold at clinics and pharmacies across the US as a prescribed medicine between July 2013 and August 2015.
Headquartered in New Jersey, Merck is considered to be one of the largest pharmaceutical companies in the world. The company reported global sales worth $42.2bn in 2014.
Image: The consumption of Temodar and Temozolomide by children can lead to poisoning. Photo: courtesy of US Consumer Product Safety Commission.